Ionis Pharmaceuticals, Inc.
(NASDAQ : IONS)

( )
IONS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.87%204.661.3%$437.29m
BIIBBiogen Inc.
0.13%226.061.3%$385.70m
GILDGilead Sciences, Inc.
1.23%65.300.9%$366.87m
CELGCelgene Corporation
0.56%100.951.3%$350.36m
ILMNIllumina, Inc.
0.60%312.173.5%$264.87m
REGNRegeneron Pharmaceuticals, Inc.
-0.53%303.822.6%$218.75m
EXASExact Sciences Corporation
5.16%99.7424.1%$209.91m
ALXNAlexion Pharmaceuticals, Inc.
3.42%104.812.0%$187.13m
VRTXVertex Pharmaceuticals Incorporated
1.47%176.141.9%$179.12m
AAgilent Technologies, Inc.
0.76%75.751.6%$150.80m
SRPTSarepta Therapeutics, Inc.
2.74%88.0514.6%$142.65m
ALDRAlder Biopharmaceuticals, Inc.
-0.21%18.8810.2%$128.87m
BMRNBioMarin Pharmaceutical Inc.
1.89%68.514.3%$96.67m
ACADACADIA Pharmaceuticals Inc.
1.72%40.1613.4%$89.24m
SGENSeattle Genetics, Inc.
1.17%83.386.2%$85.21m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.